PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

Castaneda CA, Lopez-Ilasaca M, Pinto JA, Chirinos-Arias M, Doimi F, Neciosup SP, Rojas KI, Vidaurre T, Balko JM, Arteaga CL, Gomez HL
Hematol Oncol Stem Cell Ther. 2014 7 (4): 142-8

PMID: 25467032 · DOI:10.1016/j.hemonc.2014.09.007

MeSH Terms (15)

Biomarkers, Tumor Breast Neoplasms Class I Phosphatidylinositol 3-Kinases Cohort Studies Exons Female Gene Amplification Humans Middle Aged Mutation Neoadjuvant Therapy Peru Phosphatidylinositol 3-Kinases Receptor, ErbB-2 Triple Negative Breast Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: